FIELD: medicine, pharmacy.
SUBSTANCE: invention relates, in particular, to a solid pharmaceutical composition used in treatment and prophylaxis of osteoporosis. The composition comprises derivative of bis-phosphonic acid that involves carbohydrate alcohol-base nuclei, preferably, mannitol and uniformly distributed in a homogenous mixture of active component and filling agents. Also, invention discloses a process for preparing the composition described above. Invention eliminates the chemical instability problem of derivatives of bis-phosphonic acid that are ready for using in solid medicinal formulations and during the process for their preparing, good physical properties (strength) of the solid medicinal formulation.
EFFECT: improved and valuable medicinal and pharmaceutical properties of composition.
12 cl, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITIONS CONTAINING S1P RECEPTOR MODULATOR | 2007 |
|
RU2487703C2 |
| TABLET PREPARING BY DIRECT PRESSING AND COMPRISING 4-AMINO-1-HYDROXYBUTYLIDENE-1,1-BISPHOSPHONIC ACID AS ACTIVE COMPONENT | 2001 |
|
RU2279273C2 |
| PHARMACOLOGICAL COMPOSITION WITH SWELLING COATING | 2004 |
|
RU2375048C2 |
| ANTIVIRAL AND ANTIMICROBIAL COMPOSITION | 2008 |
|
RU2457857C2 |
| METHOD FOR PREPARING A PHARMACEUTICAL COMPOSITION COMPRISING A QUINOLINE DERIVATIVE OR SALT THEREOF | 2017 |
|
RU2735807C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING DIACEREIN | 2009 |
|
RU2542461C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING IBUPROFEN AND DOMPERIDONE FOR MIGRAINE TREATMENT | 1998 |
|
RU2195935C2 |
| NEW COMPOSITION OF LAPATINIB AS A SOLID DOSAGE FORM FOR ORAL USE AND A METHOD OF ITS MANUFACTURE | 2019 |
|
RU2821950C2 |
| PHARMACEUTICAL COMPOSITION OF ANTIHYPERTENSIVE AND DIURETIC ACTION, AND METHOD FOR ITS OBTAINING | 2002 |
|
RU2201751C1 |
| DELAYED FIXED-TIME PULSATILE RELEASE DOSAGE FORMS | 2008 |
|
RU2452472C2 |
